| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SLNO | Common Stock | Sale | $116,699 | -1,769 | -2.1% | $65.97 | 81,236 | 27 Mar 2025 | Direct | F1, F2, F3 |
| transaction | SLNO | Common Stock | Sale | $192,427 | -2,881 | -3.5% | $66.79 | 78,355 | 27 Mar 2025 | Direct | F1, F3, F4 |
| transaction | SLNO | Common Stock | Sale | $354,684 | -5,239 | -6.7% | $67.70 | 73,116 | 27 Mar 2025 | Direct | F1, F3, F5 |
| transaction | SLNO | Common Stock | Sale | $474,019 | -6,891 | -9.4% | $68.79 | 66,225 | 27 Mar 2025 | Direct | F1, F3, F6 |
| transaction | SLNO | Common Stock | Sale | $278,650 | -3,990 | -6% | $69.84 | 62,235 | 27 Mar 2025 | Direct | F1, F3, F7 |
| transaction | SLNO | Common Stock | Sale | $29,072 | -411 | -0.66% | $70.73 | 61,824 | 27 Mar 2025 | Direct | F1, F3, F8 |
| transaction | SLNO | Common Stock | Sale | $42,831 | -597 | -0.97% | $71.74 | 61,227 | 27 Mar 2025 | Direct | F1, F3, F9 |
| transaction | SLNO | Common Stock | Sale | $6,610 | -91 | -0.15% | $72.64 | 61,136 | 27 Mar 2025 | Direct | F1, F3, F10 |
| transaction | SLNO | Common Stock | Options Exercise | $24,929 | +4,888 | +8% | $5.10 | 66,024 | 27 Mar 2025 | Direct | F3 |
| transaction | SLNO | Common Stock | Options Exercise | $9,038 | +3,750 | +5.7% | $2.41 | 69,774 | 27 Mar 2025 | Direct | F3 |
| transaction | SLNO | Common Stock | Options Exercise | $168,000 | +32,000 | +46% | $5.25 | 101,774 | 27 Mar 2025 | Direct | F3 |
| transaction | SLNO | Common Stock | Sale | $3,310,080 | -50,156 | -49% | $66.00 | 51,618 | 27 Mar 2025 | Direct | F3, F11 |
| transaction | SLNO | Common Stock | Sale | $1,571,717 | -23,475 | -45% | $66.95 | 28,143 | 27 Mar 2025 | Direct | F3, F12 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SLNO | Employee stock option (right to buy) | Options Exercise | $0 | -4,888 | -67% | $0.000000 | 2,445 | 27 Mar 2025 | Common Stock | 4,888 | $5.10 | Direct | F13 |
| transaction | SLNO | Employee stock option (right to buy) | Options Exercise | $0 | -3,750 | -24% | $0.000000 | 11,667 | 27 Mar 2025 | Common Stock | 3,750 | $2.41 | Direct | F14 |
| transaction | SLNO | Employee stock option (right to buy) | Options Exercise | $0 | -32,000 | -37% | $0.000000 | 55,392 | 27 Mar 2025 | Common Stock | 32,000 | $5.25 | Direct | F15 |
| Id | Content |
|---|---|
| F1 | These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). |
| F2 | This transaction was executed in multiple trades at prices ranging from $65.15 to $66.145. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F3 | Certain of these securities are RSUs. Each RSU represents a contingent right to receive one share of Common Stock, subject to the applicable vesting schedule and conditions of each RSU. |
| F4 | This transaction was executed in multiple trades at prices ranging from $66.24 to $67.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F5 | This transaction was executed in multiple trades at prices ranging from $67.24 to $68.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F6 | This transaction was executed in multiple trades at prices ranging from $68.24 to $69.225. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F7 | This transaction was executed in multiple trades at prices ranging from $69.24 to $70.235. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F8 | This transaction was executed in multiple trades at prices ranging from $70.24 to $71.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F9 | This transaction was executed in multiple trades at prices ranging from $71.26 to $72.22. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F10 | This transaction was executed in multiple trades at prices ranging from $72.31 to $72.80. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F11 | This transaction was executed in multiple trades at prices ranging from $65.74 to $66.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F12 | This transaction was executed in multiple trades at prices ranging from $66.75 to $67.10. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| F13 | One forty-eighth (1/48th) of the shares subject to the Option shall vest on the first month anniversary of January 1, 2022 (the "Vesting Commencement Date"), and one forty-eighth (1/48th) of the total number of shares subject to the Option shall vest each month thereafter on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month), such that all of the shares subject to the Option will have vested as of the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person continuing to be a Service Provider through each such date. |
| F14 | One forty-eighth of the shares subject to the option vest on February 1, 2023 and each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider (as defined in the Issuer's 2014 Equity Incentive Plan) through each such date. |
| F15 | One thirty-sixth of the shares subject to the Option vest on June 26, 2023 and each one-month anniversary thereafter, subject to the Reporting Person continuing to be a Service Provider through each such date. |
Officer title: SVP Global Clinical Operations and Patient Advocacy